Patrick F. Monahan

Patrick F. Monahan discloses dealings in Igene Biotechnology Inc to SEC (Form 4). Over a trading history stretching from 15 October 2007 to 16 July 2009, the count stands at 3 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 23 July 2009: an option exercise of €21k, in Igene Biotechnology Inc. Typically, a trade is published a median of 7 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.